These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24738000)

  • 1. Effects of long-term testosterone therapy on patients with "diabesity": results of observational studies of pooled analyses in obese hypogonadal men with type 2 diabetes.
    Haider A; Yassin A; Doros G; Saad F
    Int J Endocrinol; 2014; 2014():683515. PubMed ID: 24738000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study.
    Traish AM; Haider A; Doros G; Saad F
    Int J Clin Pract; 2014 Mar; 68(3):314-29. PubMed ID: 24127736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of 11 years of long-term injectable testosterone undecanoate therapy on anthropometric and metabolic parameters in hypogonadal men with normal weight, overweight and obesity in comparison with untreated controls: real-world data from a controlled registry study.
    Saad F; Doros G; Haider KS; Haider A
    Int J Obes (Lond); 2020 Jun; 44(6):1264-1278. PubMed ID: 32060355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-term treatment with testosterone on weight and waist size in 411 hypogonadal men with obesity classes I-III: observational data from two registry studies.
    Saad F; Yassin A; Doros G; Haider A
    Int J Obes (Lond); 2016 Jan; 40(1):162-70. PubMed ID: 26219417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone therapy in hypogonadal men results in sustained and clinically meaningful weight loss.
    Yassin A; Doros G
    Clin Obes; 2013 Jun; 3(3-4):73-83. PubMed ID: 24163704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of continuous long-term testosterone therapy (TTh) on anthropometric, endocrine and metabolic parameters for up to 10 years in 115 hypogonadal elderly men: real-life experience from an observational registry study.
    Yassin AA; Nettleship J; Almehmadi Y; Salman M; Saad F
    Andrologia; 2016 Sep; 48(7):793-9. PubMed ID: 26762680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roux-en-Y Gastric Bypass Versus Medical Treatment for Type 2 Diabetes Mellitus in Obese Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Yan Y; Sha Y; Yao G; Wang S; Kong F; Liu H; Zhang G; Zhang H; Hu C; Zhang X
    Medicine (Baltimore); 2016 Apr; 95(17):e3462. PubMed ID: 27124041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remission of type 2 diabetes following long-term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11-year data from a real-world registry study.
    Haider KS; Haider A; Saad F; Doros G; Hanefeld M; Dhindsa S; Dandona P; Traish A
    Diabetes Obes Metab; 2020 Nov; 22(11):2055-2068. PubMed ID: 32558149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-term testosterone replacement therapy, with a temporary intermission, on glycemic control of nine hypogonadal men with type 1 diabetes mellitus - a series of case reports.
    Saad F; Yassin A; Almehmadi Y; Doros G; Gooren L
    Aging Male; 2015; 18(3):164-8. PubMed ID: 26075537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes.
    Kapoor D; Goodwin E; Channer KS; Jones TH
    Eur J Endocrinol; 2006 Jun; 154(6):899-906. PubMed ID: 16728551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life.
    Yassin DJ; Doros G; Hammerer PG; Yassin AA
    J Sex Med; 2014 Jun; 11(6):1567-76. PubMed ID: 24712761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Men with testosterone deficiency and a history of cardiovascular diseases benefit from long-term testosterone therapy: observational, real-life data from a registry study.
    Haider A; Yassin A; Haider KS; Doros G; Saad F; Rosano GM
    Vasc Health Risk Manag; 2016; 12():251-61. PubMed ID: 27366080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visceral Adiposity Measurements, Metabolic and Inflammatory Profi le in Obese Patients with and Without Type 2 Diabetes Mellitus: A Crosssectional Analysis.
    Wanderley Rocha DR; Jorge AR; Braulio VB; Arbex AK; Marcadenti A
    Curr Diabetes Rev; 2017; 13(1):11-18. PubMed ID: 26467189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone Therapy and Glucose Homeostasis in Men with Testosterone Deficiency (Hypogonadism).
    Saad F
    Adv Exp Med Biol; 2017; 1043():527-558. PubMed ID: 29224109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Body mass index, waist circumference and waist-to-height ratio associated with the incidence of type 2 diabetes mellitus: a cohort study].
    Yang XY; Zhang M; Luo XP; Wang JJ; Yin L; Pang C; Wang GA; Shen YX; Wu DT; Zhang L; Ren YC; Wang BY; Zhang HY; Zhou JM; Han CY; Zhao Y; Feng TP; Hu DS; Zhao JZ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Apr; 50(4):328-33. PubMed ID: 27029364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative androgen deficiency in relation to obesity and metabolic status in older men.
    Chen RY; Wittert GA; Andrews GR
    Diabetes Obes Metab; 2006 Jul; 8(4):429-35. PubMed ID: 16776750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triglyceride predicts cardiovascular mortality and its relationship with glycaemia and obesity in Chinese type 2 diabetic patients.
    Chan WB; Tong PC; Chow CC; So WY; Ng MC; Ma RC; Osaki R; Cockram CS; Chan JC
    Diabetes Metab Res Rev; 2005; 21(2):183-8. PubMed ID: 15386811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone Replacement Therapy: Effects on Blood Pressure in Hypogonadal Men.
    Hackett G; Mann A; Haider A; Haider KS; Desnerck P; König CS; Strange RC; Ramachandran S
    World J Mens Health; 2024 Feb; ():. PubMed ID: 38449452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of testosterone supplementation therapy on lipid metabolism in hypogonadal men with T2DM: a meta-analysis of randomized controlled trials.
    Zhang KS; Zhao MJ; An Q; Jia YF; Fu LL; Xu JF; Gu YQ
    Andrology; 2018 Jan; 6(1):37-46. PubMed ID: 28950433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.